Castenmiller Charlotte, Nagy Noémi Anna, Kroon Pascal Zion, Auger Lydia, Desgagnés Réjean, Martel Caroline, Mirande Lucie, Morel Bertrand, Roberge Joannie, Stordeur Virginie, Tropper Guy, Vézina Louis Philipe, van Ree Ronald, Gomord Véronique, de Jong Esther Christina
Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, the Netherlands.
Angany Inc., Québec, Canada.
World Allergy Organ J. 2023 Nov 10;16(11):100839. doi: 10.1016/j.waojou.2023.100839. eCollection 2023 Nov.
As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived Bioparticles (BPs) surface expressing Ara h 2 at high density have been shown to be very hypoallergenic. Here, we assessed the dendritic cell (DC)-activating and T cell polarization capacity of these peanut-specific BPs.
Route and kinetics of BP uptake were studied by (imaging) flow cytometry using monocyte-derived DCs incubated with fluorescently-labelled Ara h 2 BPs or natural Ara h 2 (nAra h 2) in the presence or absence of inhibitors that block pathways involved in macropinocytosis, phagocytosis, and/or receptor-mediated uptake. DC activation was monitored by flow cytometry (maturation marker expression) and ELISA (cytokine production). T cell polarization was assessed by co-culturing DCs exposed to Ara h 2 BPs or nAra h 2 with naïve CD4 T cells, followed by flow cytometry assessment of intracellular IFNγ (Th1) and IL-13 (Th2), and CD25CD127Foxp3 regulatory T cells (Tregs). The suppressive activity of Tregs was tested using a suppressor assay.
Ara h 2 BPs were taken up by DCs through actin-dependent pathways. They activated DCs demonstrated by an induced expression of CD83 and CD86, and production of TNFα, IL-6, and IL-10. BP-treated DCs polarized naïve CD4 T cells towards Th1 cells, while reducing Th2 cell development. Furthermore, BP-treated DCs induced reduced the frequency of Foxp3 Tregs but did not significantly affect T cell IL-10 production or T cells with suppressive capacity. In contrast, DC activation and Th1 cell polarization were not observed for nAra h 2.
Ara h 2 BPs activate DCs that subsequently promote Th1 cell polarization and reduce Th2 cell polarization. These characteristics mark Ara h 2 BPs as a promising novel candidate for peanut AIT.
由于唯一获得市场授权用于花生过敏的变应原免疫疗法(AIT)伴有高副作用风险,且主要诱导强烈的脱敏反应但疗效不能持久,因此需要新的治疗选择。已证明高密度表面表达Ara h 2的花生特异性植物源生物颗粒(BPs)具有极低的过敏原性。在此,我们评估了这些花生特异性BPs激活树突状细胞(DC)和T细胞极化的能力。
通过(成像)流式细胞术研究BP摄取的途径和动力学,使用单核细胞衍生的DC与荧光标记的Ara h 2 BPs或天然Ara h 2(nAra h 2)孵育,同时存在或不存在阻断巨胞饮作用、吞噬作用和/或受体介导摄取相关途径的抑制剂。通过流式细胞术(成熟标志物表达)和ELISA(细胞因子产生)监测DC激活。通过将暴露于Ara h 2 BPs或nAra h 2的DC与初始CD4 T细胞共培养来评估T细胞极化,随后通过流式细胞术评估细胞内IFNγ(Th1)和IL-13(Th2),以及CD25CD127Foxp3调节性T细胞(Tregs)。使用抑制试验测试Tregs的抑制活性。
Ara h 2 BPs通过肌动蛋白依赖性途径被DC摄取。它们激活DC,表现为CD83和CD86的诱导表达以及TNFα、IL-6和IL-10的产生。经BP处理的DC将初始CD4 T细胞极化为Th1细胞,同时减少Th2细胞发育。此外,经BP处理的DC诱导Foxp3 Tregs频率降低,但对T细胞IL-10产生或具有抑制能力的T细胞没有显著影响。相比之下,nAra h 2未观察到DC激活和Th1细胞极化。
Ara h 2 BPs激活DC,随后促进Th1细胞极化并减少Th2细胞极化。这些特性使Ara h 2 BPs成为花生AIT有前景的新候选物。